Australia’s BioDiscovery Company
Welcome to
Microbial Screening Technologies
As one of the planet’s megadiverse countries, Australia’s microbial biodiversity is vast, unique, and largely unexplored.
Since 1994, MST has dedicated its research to harnessing microorganisms for biodiscovery, building a remarkable library of bioactive strains, extracts and metabolites.
Discover the untapped potential of MST’s unique microbial and natural product resources, where innovation and scientific excellence meet biodiversity.
How we can help you
Opportunities
From targeted biodiscovery projects to providing pure microbial metabolites for integration into your R&D program, MST offers our extensive natural product resources to accelerate your product development.
The Microbial Ark
MST’s culture library of over 500,000 microorganisms is isolated from a diverse range of environments, with a special focus on continental Australia and Tasmania. Our resources library includes soils, marine samples, plants, lichens and insects.
Metabolic & Chemical Diversity
We are the experts in microbial chemistry, strain isolation and cultivation.
Our extensively characterized culture library enables us to create a diverse range of specialized, targeted collections
Technology
Combined with MST’s proprietary bioinformatics and chemometrics, our trove of chemical and biological data places us at the leading edge of natural product discovery
News
MST’s decades of R&D have produced hundreds of research articles, patents, and industry reports. With 10 publications of new species and novel metabolites each year, we are at the forefront of microbial discovery.
BioAustralis
Rare metabolites, derived from MST’s internal discovery program, are our specialty. Over 5,000 known metabolites are available for purchase as fine chemicals.
Stay in the loop
Recent publications
Fungal Duel between Penicillium brasilianum and Aspergillus nomius Results in Dual Induction of Miktospiromide A and Kitrinomycin A
Michael S. Cowled, John A. Kalaitzis, Andrew Crombie, Rachel Chen, Nicolau Sbaraini, Ernest Lacey, and Andrew M. Piggott J. Nat. Prod. 2023, 86, 10, 2398–2406 Publication Date: September 22, 2023 https://doi.org/10.1021/acs.jnatprod.3c00593 Abstract: Cocultivation of...
Drug susceptibility testing for oxygen-dependent and oxygen-independent resistance phenotypes in trichomonads
Alexander Y.F. Lam, Ernest Lacey, Vesna De Petra, Deborah A Williamson, Jan Šlapeta, Aaron R. Jex, Samantha J. Emery-Corbin Publication Date: November 26, 2022 https://doi.org/10.1016/j.ijpara.2022.11.010 Abstract: Trichomonas vaginalis is the most prevalent,...
Turonicin A, an Antifungal Linear Polyene Polyketide from an Australian Streptomyces sp.
Rachel Chen, Scott A. Minns, John A. Kalaitzis, Mark S. Butler, Maira Rosin, Daniel Vuong, Soo Sum Lean, Yit-Heng Chooi, Ernest Lacey, and Andrew M. Piggott J. Nat. Prod. 2023, 86, 8, 2054–2058 Publication Date: August 1, 2023...